vs

Side-by-side financial comparison of CoStar Group (CSGP) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $899.9M, roughly 1.1× CoStar Group). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs 5.2%, a 0.3% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 26.9%). CoStar Group produced more free cash flow last quarter ($101.3M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 17.1%).

CoStar Group, Inc. is an American provider of information, analytics, and marketing services to the commercial property industry in North America and Europe. Founded in 1987 by Andrew C. Florance and based in Arlington, Virginia, the company operates the CoStar online database and news website and several online marketplaces, including Apartments.com and Homes.com.

CSGP vs ECG — Head-to-Head

Bigger by revenue
ECG
ECG
1.1× larger
ECG
$1.0B
$899.9M
CSGP
Growing faster (revenue YoY)
ECG
ECG
+6.3% gap
ECG
33.2%
26.9%
CSGP
Higher net margin
ECG
ECG
0.3% more per $
ECG
5.5%
5.2%
CSGP
More free cash flow
CSGP
CSGP
$77.8M more FCF
CSGP
$101.3M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
17.1%
CSGP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CSGP
CSGP
ECG
ECG
Revenue
$899.9M
$1.0B
Net Profit
$46.5M
$55.3M
Gross Margin
78.6%
11.6%
Operating Margin
5.5%
6.8%
Net Margin
5.2%
5.5%
Revenue YoY
26.9%
33.2%
Net Profit YoY
-22.2%
60.4%
EPS (diluted)
$0.12
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSGP
CSGP
ECG
ECG
Q4 25
$899.9M
$1.0B
Q3 25
$833.6M
$986.8M
Q2 25
$781.3M
$921.5M
Q1 25
$732.2M
$826.6M
Q4 24
$709.4M
$759.6M
Q3 24
$692.6M
$761.0M
Q2 24
$677.8M
$703.4M
Q1 24
$656.4M
$625.7M
Net Profit
CSGP
CSGP
ECG
ECG
Q4 25
$46.5M
$55.3M
Q3 25
$-30.9M
$57.0M
Q2 25
$6.2M
$52.8M
Q1 25
$-14.8M
$36.7M
Q4 24
$59.8M
$34.5M
Q3 24
$53.0M
$41.8M
Q2 24
$19.2M
$39.0M
Q1 24
$6.7M
$28.2M
Gross Margin
CSGP
CSGP
ECG
ECG
Q4 25
78.6%
11.6%
Q3 25
79.3%
12.6%
Q2 25
78.5%
13.0%
Q1 25
79.1%
11.2%
Q4 24
80.1%
11.4%
Q3 24
79.7%
11.8%
Q2 24
80.0%
12.6%
Q1 24
78.5%
11.9%
Operating Margin
CSGP
CSGP
ECG
ECG
Q4 25
5.5%
6.8%
Q3 25
-6.1%
7.3%
Q2 25
-3.5%
7.9%
Q1 25
-5.8%
6.2%
Q4 24
5.6%
6.1%
Q3 24
3.4%
7.1%
Q2 24
-2.4%
7.3%
Q1 24
-6.5%
6.2%
Net Margin
CSGP
CSGP
ECG
ECG
Q4 25
5.2%
5.5%
Q3 25
-3.7%
5.8%
Q2 25
0.8%
5.7%
Q1 25
-2.0%
4.4%
Q4 24
8.4%
4.5%
Q3 24
7.7%
5.5%
Q2 24
2.8%
5.5%
Q1 24
1.0%
4.5%
EPS (diluted)
CSGP
CSGP
ECG
ECG
Q4 25
$0.12
$1.09
Q3 25
$-0.07
$1.11
Q2 25
$0.01
$1.03
Q1 25
$-0.04
$0.72
Q4 24
$0.14
$0.68
Q3 24
$0.13
$0.82
Q2 24
$0.05
$0.76
Q1 24
$0.02
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSGP
CSGP
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
$1.6B
Total DebtLower is stronger
$140.0M
$281.5M
Stockholders' EquityBook value
$8.3B
$629.8M
Total Assets
$10.5B
$1.7B
Debt / EquityLower = less leverage
0.02×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSGP
CSGP
ECG
ECG
Q4 25
$1.6B
Q3 25
$1.9B
Q2 25
$3.6B
Q1 25
$3.7B
Q4 24
$4.7B
Q3 24
$553.0K
Q2 24
Q1 24
Total Debt
CSGP
CSGP
ECG
ECG
Q4 25
$140.0M
$281.5M
Q3 25
$1.0B
$285.1M
Q2 25
$1.0B
$288.6M
Q1 25
$1.0B
$292.1M
Q4 24
$1.0B
$295.6M
Q3 24
$1.0B
Q2 24
$1.0B
Q1 24
$1.0B
Stockholders' Equity
CSGP
CSGP
ECG
ECG
Q4 25
$8.3B
$629.8M
Q3 25
$8.6B
$573.0M
Q2 25
$8.6B
$514.4M
Q1 25
$8.6B
$460.2M
Q4 24
$7.6B
$422.6M
Q3 24
$7.5B
$453.3M
Q2 24
$7.4B
$490.0M
Q1 24
$7.3B
$464.3M
Total Assets
CSGP
CSGP
ECG
ECG
Q4 25
$10.5B
$1.7B
Q3 25
$10.8B
$1.6B
Q2 25
$10.5B
$1.5B
Q1 25
$10.4B
$1.4B
Q4 24
$9.3B
$1.3B
Q3 24
$9.1B
$1.3B
Q2 24
$9.1B
Q1 24
$9.0B
Debt / Equity
CSGP
CSGP
ECG
ECG
Q4 25
0.02×
0.45×
Q3 25
0.12×
0.50×
Q2 25
0.12×
0.56×
Q1 25
0.12×
0.63×
Q4 24
0.13×
0.70×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSGP
CSGP
ECG
ECG
Operating Cash FlowLast quarter
$162.1M
$48.2M
Free Cash FlowOCF − Capex
$101.3M
$23.5M
FCF MarginFCF / Revenue
11.3%
2.3%
Capex IntensityCapex / Revenue
6.8%
2.4%
Cash ConversionOCF / Net Profit
3.49×
0.87×
TTM Free Cash FlowTrailing 4 quarters
$123.0M
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSGP
CSGP
ECG
ECG
Q4 25
$162.1M
$48.2M
Q3 25
$68.2M
$76.2M
Q2 25
$146.5M
$25.3M
Q1 25
$53.2M
$7.1M
Q4 24
$94.6M
Q3 24
$100.3M
$78.9M
Q2 24
$58.1M
Q1 24
$139.6M
$21.9M
Free Cash Flow
CSGP
CSGP
ECG
ECG
Q4 25
$101.3M
$23.5M
Q3 25
$-5.5M
$65.7M
Q2 25
$27.7M
$12.3M
Q1 25
$-500.0K
$-11.4M
Q4 24
$25.2M
Q3 24
$40.2M
$60.9M
Q2 24
$-14.7M
Q1 24
$-237.1M
$12.6M
FCF Margin
CSGP
CSGP
ECG
ECG
Q4 25
11.3%
2.3%
Q3 25
-0.7%
6.7%
Q2 25
3.5%
1.3%
Q1 25
-0.1%
-1.4%
Q4 24
3.6%
Q3 24
5.8%
8.0%
Q2 24
-2.2%
Q1 24
-36.1%
2.0%
Capex Intensity
CSGP
CSGP
ECG
ECG
Q4 25
6.8%
2.4%
Q3 25
8.8%
1.1%
Q2 25
15.2%
1.4%
Q1 25
7.3%
2.2%
Q4 24
9.8%
Q3 24
8.7%
2.4%
Q2 24
10.7%
Q1 24
57.4%
1.5%
Cash Conversion
CSGP
CSGP
ECG
ECG
Q4 25
3.49×
0.87×
Q3 25
1.34×
Q2 25
23.63×
0.48×
Q1 25
0.19×
Q4 24
1.58×
Q3 24
1.89×
1.89×
Q2 24
3.03×
Q1 24
20.84×
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSGP
CSGP

Co Star$503.8M56%
Other$283.0M31%
Loop Net$94.7M11%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons